News
BIOCORP vereinbart neue Partnerschaft mit H&T über InspairTM
Aufsichtsrechtliche Meldungen:
BIOCORP (Paris:ALCOR) (FR0012788065 - ALCOR / Eligible PEA-PME), ein französisches Unternehmen, das sich auf die Konzeption, Entwicklung und Herstellung innovativer
BIOCORP Signs New Partnership Around InspairTM With H&T Presspart
Regulatory News:
BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / Eligible PEA‐PME), a French company specialized in the design, development, and manufacturing of innovative medical devices
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
EssilorLuxottica Aktie: Anleger werden sich richtig freuen!
Fundamental: Derzeit liegt das Kurs-Gewinn-Verhältnis (KGV) bei 32,42. Das bedeutet, für jeden Euro Gewinn von EssilorLuxottica zahlt die Börse 32,42 Euro. Dies sind 58 Prozent weniger als für....
EssilorLuxottica Aktie: Positive Aussichten!
Fundamental: Der wichtigste Indikator für die fundamentale Analyse ist das Kurs-Gewinn-Verhältnis (KGV). Auf dessen Basis ist EssilorLuxottica mit einem Wert von 29,55 deutlich günstiger als das....